Synthetic glycopeptides for the development of tumour-selective vaccines

Journal of Peptide Science

Volumn 9, Issue 9, 2003, Pages 563-573

  Kunz, Horst ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Allylic anchor (HYCRON); Glycopeptides; MUCI mucin; Sialyl T antigen; Sialyl Tn antigen; Solid phase synthesis; Synthetic antitumour vaccines; Tumour associated antigens

Indexed keywords

ALLYL COMPOUND; AMINO ACID; BETA GALACTOSIDASE; CARBOHYDRATE ANTIGEN; CD3 ANTIGEN; EPITOPE; GLYCOPEPTIDE; GLYCOPHORIN A; LACTOSE; LEUKOSIALIN; MORPHOLINE; MUCIN 1; PALLADIUM; SERINE DERIVATIVE; SIALIC ACID DERIVATIVE; SIALYLTRANSFERASE; SYNTHETIC PEPTIDE; TETANUS TOXIN; THREONINE; TUMOR VACCINE;

ACIDITY; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CATALYSIS; CHEMICAL REACTION; CYTOTOXIC T LYMPHOCYTE; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; EPITHELIUM; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; SOLID; TANDEM REPEAT;

AMINO ACID SEQUENCE; ANIMALS; CA-15-3 ANTIGEN; CANCER VACCINES; CARBOHYDRATE SEQUENCE; EPITHELIUM; GLYCOPEPTIDES; GLYCOPHORIN; HUMANS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE;

EID: 0141504031     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.477     Document Type: Article

References (39)

1. Fischer E. Ueber einige Derivate des Glycokolls, Alanins und Leucins. Ber. Dtsch. Chem. Ges. 1902; 35: 1095.
2. Fischer E. Ueber Caffein, Theobromin, Xanthin und Guanin. Justus Liebigs Ann. Chem. 1882; 215: 253.
3. Fischer E. Synthesen in der Zuckergruppe. Ber. Dtsch. Chem. Ges. 1890; 23: 2114.
4. Fischer E. Untersuchungen ueber Aminosaeuren, Polypeptide und Proteine I (1899-1906). Verlag J. Springer: Berlin, 1923.
5. Helferich B. Emil Fischer zum 100. Geburtstag. Angew. Chem. 1953; 65: 45.
6. Kunz H. Emil Fischer-Unequalled classicist, master of organic chemistry research, and inspired trailblazer of biological chemistry. Angew. Chem. Int. Ed. 2002; 41: 4439-4451.
7. Gottschalk A. Glycoproteins: Their Composition, Structure and Function. Elsevier: Amsterdam, 1972.
8. Landsteiner K. Ueber Agglutinationserscheinungen normalen menschlichen Blutes. Wiener Kl. Wochenschr. 1901; 14: 1132-1134.
9. For example, see: Dwek RA. Glycobiology: Towards understanding the function of sugars. Chem. Rev. 1996; 96: 683.
10. Hakomori S. Tumor-associated carbohydrate antigens. Am. Rev. Immunol. 1984; 2: 103-126.
11. Feizi T, Childs RA. Carbohydrate structures of glycoproteins and glycolipids as differentiation antigens, tumor-associated antigens and components of receptor systems. Trends Biochem. Sci. 1985; 10: 24-29.
12. Springer GF. T and Tn, general carcinoma autoantigens. Science 1984; 224: 1198.
13. Springer GF, Desai RR, Fry WA, Goodale RL, Shearen JG, Scanlon EF. T antigen, a tumor marker against which breast, lung and pancreas carcinoma patients mount immune responses. Cancer Detect. Prev. 1983: 6: 111-118.
14. Tomita M, Marchesi VF. Amino acid sequence and oligosaccharide attachment sites of human erythrocyte glycophorin. Proc. Nat Acad. Sci. USA 1975; 72: 2964-2968.
15. N- and T-antigen type and their binding to bovine serum albumin. Angew. Chem. Int. Ed. Engl. 1986; 25: 360-362.
16. N an T antigen structures and their coupling to bovine serum albumin. Carbohydr. Res. 1990; 202: 207-223.
17. Dippold W, Steinborn A, Meyer zum Büschenfelde KH. The role of the Thomsen-Friedenreich antigen as a tumor-associated molecule. Environ. Health Persp. 1990; 88: 255-257; Steinborn A. PhD Thesis, University of Mainz. 1990.
18. Kunz H, Liebe B, Dippold W, Claus C, Habermann J, Sprengard U, Peilstöcker K, Rösch M. Medicinal Chemistry into the Millennium, Campell ME, Blagbrough IS (eds). The Royal Society of Chemistry, Cambridge 2002; 245-257.
19. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, Dutzig N, Peal J, Burchell J, Pemberton L, Lalani EN, Wilson D. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J. Biol. Chem. 1990; 15 286-15 293.
20. Taylor-Papadimitriou J, Burchell J, Miles DW, Dalziel M. MUCI and cancer. Biochim. Biophys. Acta 1999; 1455: 301-313.
21. N and T antigen glycopeptide sequences of tumor-associated MUCl using S-pent-4-enyl thioglycosides. J. Prakt. Chem. 1997; 339: 322-334.
22. Seitz O, Kunz H. A novel allylic anchor for solid-phase synthesis-synthesis of protected and unprotected O-glycosylated mucin-type glycopeptides. Angew. Chem. Int. Ed. Engl. 1995; 34: 803-805.
23. N-antigen structure. Bioorg. Med. Chem. 1993: 1: 197-207.
24. Liebe B, Kunz H. Synthesis of sialyl-Tn antigen. Regioselective sialylation of a galactosamine threonine conjugate unblocked in the carbohydrate portion. Tetrahedron Lett. 1994; 35: 8777-8778.
25. Kunz H, Dombo B. Solid phase synthesis of peptides and glycopeptides on polymeric supports with allylic anchor groups. Angew. Chem. Int. Ed. Engl. 1988; 27: 711-713.
26. Seitz O, Kunz H. HYCRON, an allylic anchor for high-efficiency solid phase synthesis of protected peptides and glycopeptides. J. Org. Chem. 1997; 62: 813-826.
27. N-glycopeptide of the MUCI repeating unit. Helv. Chim. Acta. 1997; 80: 1473-1482.
28. N-antigen glycopeptide with a partial sequence of the tandem repeat of the MUCl mucin. Angew. Chem. Int. Ed. Engl. 1997; 36: 618-621.
29. Marra A, Sinaÿ P. A novel stereoselective synthesis of N-acetyl-α-neuraminosyl-galactose disaccharide derivatives, using anomeric S-glycosyl xanthates. Carbohydr. Res. 1990; 195: 303-308.
30. Dasgupta F, Garegg PJ. Use of sulfenyl halides in carbohydrate reactions. Part I. Alkyl sulfenyl triflate as activator in the thioglycoside-mediated formation of β-glycosidic linkages during oligosaccharide synthesis. Carbohydr. Res. 1984; 177: C13-C17.
31. Knorr R, Trzeciak A, Bannwarth W. New coupling reagents in peptide chemistry. Tetrahedron Lett. 1989; 30: 1927-1930.
32. Keil S, Claus C, Dippold W, Kunz H. Towards the development of antitumor vaccines: A synthetic conjugate of a tumor-associated MUCI glycopeptide antigen and a tetanus toxin epitope. Angew. Chem. Int Ed. 2001; 40: 366-369.
33. Burchell J, Taylor-Papadimitriou J, Boshell M, Gendler S, Duhig T. A short sequence within the amino acid repeat of a cancer associated mucin contains immunodominant epitopes. Int J. Cancer. 1989: 44: 691-697.
34. Price MR, Sekowski M, Tendler SJB. Purification of anti-epithelial mucin monoclonal antibodies by epitope affinity chromatography. J. Immunol. Meth. 1991; 139: 83-90.
35. Carpino LA, El-Faham AS, Minor C, Albericio F. Advantageous application of azabenzotriazole (triazolo-pyridine)-based coupling reagents to solid-phase peptide synthesis. J. Chem. Soc. Chem. Commun. 1994; 201-203.
36. Bézay N, Dudziak G, Liese A, Kunz H. Chemoenzymatic-chemical synthesis of a (2-3)-siayl T threonine building block and its application to the synthesis of the N-terminal sequence of leukaemia-associated leukosialin (CD43). Angew. Chem. Int. Ed. 2001; 40: 2292-2295.
37. Dudziak G, Bézay N, Schwientek T, Clausen H, Kunz H, Liese A. Cyclodextrin-assisted glycan chain extension on a protected glycosyl amino acid. Tetrahedron 2000; 56: 5865-5869.
38. Fukuda M. Leukosialin, a major O-glycan-containing sialoglycoprotein defining leukocyte differentiation and malignancy. Glycobiology 1991; 1: 347-356.
39. Wang SS. p-Alkoxybenzyl alcohol resin and p-alkoxybenyzlcarbonylhydrazide resin for solid phase synthesis of protected peptide fragments. J. Am. Chem. Soc. 1973; 95: 1328.